title: Angiotensin receptor blocker and calcium channel blocker combination prevents cardiovascular events in CKD better than high-dose ARB alone.
authors.forename: Keng T
authors.initials: KT
authors.lastname: Woo
authors.forename: Kok S
authors.initials: KS
authors.lastname: Wong
authors.forename: Hui L
authors.initials: HL
authors.lastname: Choong
authors.forename: Marjorie W Y
authors.initials: MW
authors.lastname: Foo
authors.forename: Han K
authors.initials: HK
authors.lastname: Tan
authors.forename: Choong M
authors.initials: CM
authors.lastname: Chan
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000453:epidemiology*; D008297:Male; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000453:epidemiology*
chemical_list: D057911:Angiotensin Receptor Antagonists; D002121:Calcium Channel Blockers